Golden has been acquired by ComplyAdvantage.Read about it here ⟶

PeptiMed, Inc.

PeptiMed, Inc. is a Madison, Wisconsin-based biotechnology company that develops therapeutic drugs targeting the EVI1 gene for the treatment of skin, breast, lung, prostate, and ovarian cancers.

Overview Structured Data Issues Contributors Activity

peptimed.com

Is a

Organization

Company

Company attributes

Industry

Location

B2X

CEO

Founder

Date Incorporated

2012

Number of Employees (Ranges)

1 – 10

Full Address

921 Walsh Road Suite 208 Madison, WI 53714 United States

CIK Number

1,678,032

Total Funding Amount (USD)

500,000

Latest Funding Round Date

May 2017

Latest Funding Type

Seed

Patents Assigned (Count)

Other attributes

Company Operating Status

Closed

PeptiMed, Inc. is a Wisconsin-based company founded in 2012 by Scott Schneider. It operates as a biotechnology company that develops therapeutic drugs targeting the EVI1 gene for the treatment of skin, breast, lung, prostate, and ovarian cancers.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like PeptiMed, Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API